StuartWongMD

Clinical Trials

• Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer That Cannot Be Removed By Surgery Start of enrollment: 2005 Apr 01

  Terminated

  Phase 3

• Chemotherapy and Radiation Therapy (RT) With or Without Vandetanib in Treating Patients With High-Risk Stage III or Stage IV Head and Neck Cancer Start of enrollment: 2008 Nov 01

  Terminated

  Phase 2

• Dasatinib in Treating Patients With Recurrent or Metastatic Malignant Salivary Gland Tumors Start of enrollment: 2009 Mar 16

  Completed

  Phase 2

• A Study in Advanced Solid Tumors Start of enrollment: 2010 Jun 01

  Completed

  Phase 2

• Ipilimumab With or Without High-Dose Recombinant Interferon Alfa-2b in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by Surgery Start of enrollment: 2013 Jan 18

  Active, not recruiting

  Phase 2

• TRYHARD: Radiation Therapy Plus Cisplatin With or Without Lapatinib in Treating Patients With Head and Neck Cancer. Start of enrollment: 2013 Mar 15

  Completed

  Phase 2

• Chemotherapy Plus Cetuximab in Combination With VTX-2337 in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck Start of enrollment: 2013 Oct 14

  Completed

  Phase 2

• Transoral Surgery Followed By Low-Dose or Standard-Dose Radiation Therapy With or Without Chemotherapy in Treating Patients With HPV Positive Stage III-IVA Oropharyngeal Cancer Start of enrollment: 2014 Jan 22

  Active, not recruiting

  Phase 2

• Ipilimumab With or Without Bevacizumab in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by Surgery Start of enrollment: 2014 Jan 24

  Active, not recruiting

  Phase 2

• Smartphone Pain App for Assessing Oral Mucositis Pain in Patients Start of enrollment: 2018 Feb 13

  Active, not recruiting

• Pharmacokinetic (PK) Analysis of Antitumor B in Patients With Oral Cancer Start of enrollment: 2021 Aug 24

  Active, not recruiting

  Early Phase 1

• SBRT +/- Pembrolizumab in Patients With Local-Regionally Recurrent or Second Primary Head and Neck Carcinoma Start of enrollment: 2018 Nov 14

  Recruiting

  Phase 2

• Inhibition of Oral Tumorigenesis by Antitumor B Start of enrollment: 2022 Apr 22

  Recruiting

  Early Phase 1

• Transdermal Buprenorphine for the Treatment of Radiation-Induced Mucositis Pain in Head and Neck Cancer Patients Start of enrollment: 2021 Jul 08

  Active, not recruiting

  Phase 2

  Roles: Contact, Principal Investigator

• Join now to see all